
UFC Athlete, Gian Villante, Cleared of Potential Anti-Doping Policy Violation
[…] the short-term use of the Breo Ellipta inhaler was within the manufacturer’s therapeutic recommendation and was intended to return the athlete to a normal state of health without providing a performance-enhancing benefit. Finally, other permitted therapeutic alternatives were not successful at controlling the athlete’s condition. Because Villante’s TUE application was granted retroactively, his declaration […]